Highline Wealth Partners’s Amgen AMGN Stock Holding History

Highline Wealth Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$199K	Buy	472 +43	+10%	+$17.1K	0.04%	128
2026 Q2	$155K	Buy	429 +240	+127%	+$82.2K	0.03%	129
2026 Q1	$66.7K	Buy	189 +22	+13%	+$7.84K	0.02%	147
2025 Q4	$54.8K	Sell	167 -4,004	-96%	-$1.27M	0.02%	131
2025 Q3	$1.18M	Buy	4,171 +69	+2%	+$20K	0.32%	50
2025 Q2	$1.15M	Buy	4,102 +25	+0.6%	+$7.08K	0.34%	51
2025 Q1	$1.27M	Buy	4,077 +34	+0.8%	+$10K	0.43%	48
2024 Q4	$1.05M	Sell	4,043 -2	-0%	-$593	0.34%	51
2024 Q3	$1.3M	Buy	4,045 +2	+0%	+$654	0.44%	50
2024 Q2	$1.26M	Buy	4,043 +1	+0%	+$294	0.48%	47
2024 Q1	$1.15M	Hold	4,042	–	–	0.47%	50
2023 Q4	$1.16M	Buy	4,042 +30	+0.7%	+$8.17K	0.56%	43
2023 Q3	$1.08M	Hold	4,012	–	–	0.67%	36
2023 Q2	$891K	Buy	4,012 +7	+0.2%	+$1.62K	0.56%	48
2023 Q1	$968K	Hold	4,005	–	–	0.66%	43
2022 Q4	$1.05M	Hold	4,005	–	–	0.78%	38
2022 Q3	$903K	Buy	+4,005	New	+$971K	0.73%	35

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Highline Wealth Partners's AMGN Position: Q3 2026 in Review

Highline Wealth Partners increased its Amgen (AMGN) stake by 10% in Q3 2026, buying an estimated $17.1K and bringing the position to 472 shares worth $199K. The position accounts for 0.04% of the portfolio, ranked #128.

Highline Wealth Partners first reported a position in AMGN in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.3M in Q3 2024. 2,273 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Highline Wealth Partners held 472 shares of Amgen worth $199K as of Q3 2026.
Highline Wealth Partners bought 43 Amgen shares in Q3 2026, an estimated $17.1K.
Amgen made up 0.04% of Highline Wealth Partners's portfolio in Q3 2026, its #128 holding.
Highline Wealth Partners first reported a position in Amgen in Q3 2022 and has held it in 17 quarters since.
Highline Wealth Partners's Amgen position peaked at $1.3M in Q3 2024.
2,273 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.